North Capital, Inc. Biogen Inc. Transaction History
North Capital, Inc.
- $106 Billion
- Q1 2025
A detailed history of North Capital, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, North Capital, Inc. holds 438 shares of BIIB stock, worth $52,634. This represents 0.06% of its overall portfolio holdings.
Number of Shares
438Holding current value
$52,634% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,011Shares Held
127MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.01 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$1.93 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.75 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$889 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$444 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $17.3B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...